ORMP Oramed Pharmaceuticals Inc.
$4.66▼ -2.10%
Healthcare
Other
After hours
$4.69▲ +0.64%
Sep 11, 7:30 PM ET
Volume 144.3K
Avg Volume (10D) 202.7K
Key Metrics & Fundamentals
Market Cap
$193.84M
P/E Ratio
1.1
Div Yield
5.25%
52W Range
2.09 - 5.47
% vs 50 MA
4.23%
% vs 200 MA
23.15%
RSI-14
47.1
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.12
Free Cash Flow
-$202,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.74M
COGS
$0
Operating Exp
$2.77M
Operating Income
-$2.77M
EBIT
-$2.77M
Pretax Income
$101.59M
Net Income
$78.16M
EPS (Diluted)
1.84
Price & Volume History
Loading chart…
Recent News
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
GlobeNewswire · Sep 8, 2026 12:30 PM
Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO
MT Newswires · Aug 31, 2026 8:44 PM
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
Zacks Small Cap Research · Aug 28, 2026 9:30 AM
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
GlobeNewswire · Aug 17, 2026 12:00 PM
Oramed: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 9:39 PM
Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework
MT Newswires · Jul 7, 2026 9:22 PM
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
GlobeNewswire · Jul 7, 2026 8:15 PM
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
PR Newswire · Jun 25, 2026 3:35 PM
ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community
Zacks Small Cap Research · Jun 18, 2026 12:21 PM
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
PR Newswire · Jun 17, 2026 12:55 PM
Financial Overview - Income Statement
Quarterly
Mar 2025
See ORMP's money flow as a full page
Social Sentiment
No Reddit posts found for ORMP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.